No Data
gtja: Cloud applications and terminal asia vets drive industrial upgrades; AI track companies are welcoming significant development opportunities.
Tai Jun An released a research report stating that with the acceleration of AI application processes and the continuous emergence of scenario implementation cases, coupled with the dual drive of cloud applications and asia vets for industrial upgrades, companies in the AI track are ushering in important development opportunities.
Glory Announces (Hong Kong Stock) | cms (00867.HK): innovative drug GLP-1R/GCGR dual agonist CMS-D005 receives drug clinical trial approval notification.
Today's focus: cms (00867.HK): Innovative drug GLP-1R/GCGR dual agonist CMS-D005 receives drug clinical trial approval notification cms (00867.HK) announcement, the group's independently developed innovative drug CMS-D005 injection (CMS-D005) received the drug clinical trial approval notification issued by the China National Medical Products Administration on November 27, 2024. NMPA has approved the group to evaluate the safety, tolerability, and pharmacokinetics of CMS-D005 in Chinese healthy, overweight, and obese adult subjects.
Capital flow | Northbound funds net bought Hong Kong stocks worth 5.271 billion Hong Kong dollars, increasing holdings in Tencent for three consecutive days.
Track the latest trends of southbound funds.
Market Chatter: Tencent to Discontinue Nintendo Switch Service in May 2026
On November 27, tencent (00700.HK) spent 0.704 billion Hong Kong dollars to repurchase 1.77 million shares.
Gelonghui on November 27th: Tencent announced that on November 27, 2024, it spent 0.704 billion Hong Kong dollars to repurchase 1.77 million shares at a repurchase price of 392.2-405.8 Hong Kong dollars per share.
Express News | Tencent Bought Back 1.8 Mln Shares for HK$703.8 Mln on Nov 27 - HKEX Filing
No Data
No Data
No Data
MonkeyGee : buying now